Logo BSU

Please use this identifier to cite or link to this item: https://elib.bsu.by/handle/123456789/259643
Title: FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation
Authors: Gaschler, M. M.
Andia, A. A.
Liu, H.
Csuka, J. M.
Hurlocker, B.
Vaiana, C. A.
Heindel, D. W.
Zuckerman, D. S.
Bos, P. H.
Reznik, E.
Ye, L. F.
Tyurina, Y. Y.
Lin, A. J.
Shchepinov, M. S.
Chan, A. Y.
Peguero-Pereira, E.
Fomich, M. A.
Daniels, J. D.
Bekish, A. V.
Shmanai, V. V.
Kagan, V. E.
Mahal, L. K.
Woerpel, K. A.
Stockwell, B. R.
Keywords: ЭБ БГУ::ЕСТЕСТВЕННЫЕ И ТОЧНЫЕ НАУКИ::Химия
Issue Date: 2018
Publisher: Nature Publishing Group
Citation: Nat Chem Biol 2018;14(5):507-515.
Abstract: Ferroptosis is a non-apoptotic form of regulated cell death caused by the failure of the glutathione-dependent lipid-peroxide-scavenging network. FINO2 is an endoperoxide-containing 1,2-dioxolane that can initiate ferroptosis selectively in engineered cancer cells. We investigated the mechanism and structural features necessary for ferroptosis initiation by FINO2. We found that FINO2 requires both an endoperoxide moiety and a nearby hydroxyl head group to initiate ferroptosis. In contrast to previously described ferroptosis inducers, FINO2 does not inhibit system xc - or directly target the reducing enzyme GPX4, as do erastin and RSL3, respectively, nor does it deplete GPX4 protein, as does FIN56. Instead, FINO2 both indirectly inhibits GPX4 enzymatic function and directly oxidizes iron, ultimately causing widespread lipid peroxidation. These findings suggest that endoperoxides such as FINO2 can initiate a multipronged mechanism of ferroptosis.
URI: https://elib.bsu.by/handle/123456789/259643
Scopus: 10.1038/s41589-018-0031-6
metadata.dc.identifier.scopus: 85044753310
Sponsorship: We thank C. Lin for assistance with NMR spectroscopy and mass spectrometry, C. Hu for X-ray analysis, along with the Materials Research Science and Engineering Center (MRSEC) program of the National Science Foundation (NSF) under Award Numbers DMR-0820341 and DMR-1420073, and J. Chung for assistance with cell culture. This research was supported by the Training Program in Molecular Biophysics Grant (T32GM008281 to M.M.G.), the National Cancer Institute (R35CA209896 and P01CA087497 to B.R.S), the National Institute of General Medical Sciences (1RO1GM118730 to K.A.W.), the National Heart, Lung, and Blood Institute (HL114453 to V.E.K. and Y.Y.T.), the National Institute of Allergy and Infectious Diseases (U19AI068021 to V.E.K. and Y.Y.T.) and the MRSEC Program of the National Science Foundation (DMR-1420073 to E.P.-P.). The Bruker Avance-400, 500 and 600MHz spectrometers (NYU) were acquired through the support of the National Science Foundation (CHE-01162222).
Appears in Collections:Статьи химического факультета

Files in This Item:
File Description SizeFormat 
nihms943354.pdf884,71 kBAdobe PDFView/Open


PlumX

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.